Lutz Völker

Incorporated in 2002, aspect.partners is an independent and internationally acting management consulting firm of former senior executives out of the technology, healthcare and banking sector providing exceptional client focus both during and following a client project, leading to a true advisory relationship for - Corporate transformation & corporate development - Corporate transactions, structured finance - Investment advisory Sector focus: - Technology - Healthcare/Lifesciences - Financial services

Council member big data in healthcare - independent advisor to GLG

inventicsDx provides a cloud-based technology platform for Point-of-Care rapid diagnostics testing of pathogens. Lutz oversees the overall strategy and operations of invendicsDx. He is also in charge with the development of IDX' integrated diagnostic cloud technology platform providing remote instrument monitoring and control, meta-data acquisition, geo-tagging for epidemiological data and predictive analytics

BIOMES provides genome & microbiome NGS based diagnostics based on machine learning and NLP technologies for personalized and evidence-based healthcare.

In a role as strategic advisor to the BOD and Interim-CEO of Molecular Health, Inc. in Boston, MA., USA, and Molecular Health GmbH in Germany responsible for a major turn-around, implementation of a new product platform strategy and growth strategy in the US and Europe. Executed two financial rounds, implemented an EMEA and US field Operation. At this point of time Molecular Health was an investment of SAP founder Dietmar Hopp.

Incorporated in 2002, aspect.partners is an independent and internationally acting management consulting firm of former senior executives out of the technology, healthcare and banking sector providing exceptional client focus both during and following a client project, leading to a true advisory relationship for - Corporate transformation & corporate development - Corporate transactions, structured finance - Investment advisory Sector focus: - Technology - Healthcare/Lifesciences - Financial services

2004 - 2008 Balda AG, Bad Oeynhausen, ISIN: DE0005215107, Audit Committee, various joint ventures in Malaysia and China (i.e. TPK Holdings Taiwan, the first apple iPhone display manufacturer) 2007 - 2008 Realtech AG, ISIN: DE0007008906 2002 - 2006 3i Group, plc. 2003 - 2004 inubit AG, Berlin (Acquired by BOSCH Software Innovations) 1998 - 2001 Pago eTransaction GmbH, Cologne, Chairman (acquired by Deutsche Bank Card Services) 1999-2001 TellSell Consulting GmbH (Frankfurt) (Acquired by KPMG)

Member of the management board of Metro Asset Management. Co-founder, CEO and co-investor of a management holding for 5 companies in the area of eCommerce back-end services, payment services, b2b procurement services, internet booking and ticketing services for travel business and an eCommerce- and business process consultancy company. Founder of pago eTransaction GmbH (payment processing), exit to Deutsche Bank (later became DB Card Services GmbH).

General Manager of Multimedia Systems Division. Built DT's Multimedia Systems Division from scratch. Responsible for DT's strategy, implementation and market roll out of DT’S commercial internet platform: DT's eCommerce and payment solutions platform, content distribution platform, tele-medicine, collaboration and e-Learning. Establishing strategic partnership with global players, such as Microsoft, Oracle, SAP, IBM, Hewlett Packard. Responsible for various DT investments in tech start-ups, i.e INTERSHOP.

At SAP AG responsible for strategy, product development, business development and global roll out of SAP's healthcare industry solution, including SAP IS-H and ISH-med. Global market development in Europe (GER, CH, A, NL, E), USA and Asia (Singapore). Established global partnerships with IBM, HP, Ernst & Young, Siemens and Accenture.

(Previously Hewlett Packard Analytical Products Group) Productline Manager for Laboratory Data Systems and Compliance in the Process- and Pharmaceutical Industry in Europe, Middle East and Africa (EMEA). Prior to that in international R&D program management activities in Palo Alto, CA., Global Key Account Management (Bayer AG) and network consulting and professional services.

Klinische Diagnostik, Chromatographie, Statistik und Qualitätskontrolle, Labordatenverarbeitung